{"id":"https://openalex.org/W4362506830","doi":"https://doi.org/10.1007/s43440-023-00480-6","title":"A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma","display_name":"A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362506830","doi":"https://doi.org/10.1007/s43440-023-00480-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/37010783","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10227144"},"language":"en","primary_location":{"id":"doi:10.1007/s43440-023-00480-6","doi":"https://doi.org/10.1007/s43440-023-00480-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s43440-023-00480-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s43440-023-00480-6.pdf","source":{"id":"https://openalex.org/S180401253","display_name":"Pharmacological Reports","issn_l":"1734-1140","issn":["1734-1140","2299-5684"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s43440-023-00480-6.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Melissa M. Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Melissa M. Phillips","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030140723","display_name":"Iuliia Pavlyk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Iuliia Pavlyk","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071004929","display_name":"Michael D. Allen","orcid":"https://orcid.org/0000-0003-2121-8087","observed_orcids":["https://orcid.org/0000-0003-2121-8087"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Allen","raw_affiliation_strings":["Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026718910","display_name":"Essam Ahmed Ghazaly","orcid":"https://orcid.org/0000-0003-4368-8565","observed_orcids":["https://orcid.org/0000-0003-4368-8565"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"id":"https://openalex.org/I4405282191","display_name":"Medicines and Healthcare products Regulatory Agency","ror":"https://ror.org/05fan1e59","country_code":"GB","type":"government","lineage":["https://openalex.org/I4405282191"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Essam Ghazaly","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK","institution_ids":["https://openalex.org/I4405282191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053473432","display_name":"Rosalind J. Cutts","orcid":"https://orcid.org/0000-0002-8297-9341","observed_orcids":["https://orcid.org/0000-0002-8297-9341"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2799938689","display_name":"Breast Cancer Now","ror":"https://ror.org/02qa92s63","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2799938689"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rosalind Cutts","raw_affiliation_strings":["Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2799938689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040517491","display_name":"Jos\u00e9phine Carpentier","orcid":"https://orcid.org/0000-0001-8686-7729","observed_orcids":["https://orcid.org/0000-0001-8686-7729"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Josephine Carpentier","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102936617","display_name":"Joe Scott Berry","orcid":"https://orcid.org/0000-0002-4238-8651","observed_orcids":["https://orcid.org/0000-0002-4238-8651"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joe Scott Berry","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073933967","display_name":"Callum Baird Nattress","orcid":"https://orcid.org/0000-0001-9326-3632","observed_orcids":["https://orcid.org/0000-0001-9326-3632"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Callum Nattress","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046914548","display_name":"Shenghui Feng","orcid":"https://orcid.org/0000-0001-9569-6191","observed_orcids":["https://orcid.org/0000-0001-9569-6191"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Shenghui Feng","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089200111","display_name":"Gunnel Halld\u00e9n","orcid":"https://orcid.org/0000-0001-5680-2895","observed_orcids":["https://orcid.org/0000-0001-5680-2895"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gunnel Hallden","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072249752","display_name":"Claude Chelala","orcid":"https://orcid.org/0000-0002-2488-0669","observed_orcids":["https://orcid.org/0000-0002-2488-0669"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claude Chelala","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007808102","display_name":"John S. Bomalaski","orcid":"https://orcid.org/0000-0002-9454-7271","observed_orcids":["https://orcid.org/0000-0002-9454-7271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Bomalaski","raw_affiliation_strings":["Polaris Pharmaceuticals, Inc., San Diego, CA, 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polaris Pharmaceuticals, Inc., San Diego, CA, 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113661873","display_name":"Jeremy P. C. Steele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeremy Steele","raw_affiliation_strings":["Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079505616","display_name":"Michael T. Sheaff","orcid":"https://orcid.org/0000-0001-9189-0181","observed_orcids":["https://orcid.org/0000-0001-9189-0181"]},"institutions":[{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Sheaff","raw_affiliation_strings":["Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061389369","display_name":"Frances R. Balkwill","orcid":"https://orcid.org/0000-0002-5587-9759","observed_orcids":["https://orcid.org/0000-0002-5587-9759"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frances Balkwill","raw_affiliation_strings":["Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022032908","display_name":"Peter Wojciech Szlosarek","orcid":"https://orcid.org/0000-0002-5039-711X","observed_orcids":["https://orcid.org/0000-0002-5039-711X"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter W. Szlosarek","raw_affiliation_strings":["Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK. p.w.szlosarek@qmul.ac.uk","Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK. p.w.szlosarek@qmul.ac.uk","Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK"],"raw_orcid":"https://orcid.org/0000-0002-5039-711X","affiliations":[{"raw_affiliation_string":"Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK. p.w.szlosarek@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK. p.w.szlosarek@qmul.ac.uk","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"raw_affiliation_string":"Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5022032908"],"corresponding_institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I166337079","https://openalex.org/I225661044","https://openalex.org/I2801316944","https://openalex.org/I4405264518"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":0.5456,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.57566647,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"75","issue":"3","first_page":"570","last_page":"584"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6693999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6693999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.16779999434947968,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.07540000230073929,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adi-peg20","display_name":"ADI-PEG20","score":0.8939999938011169},{"id":"https://openalex.org/keywords/arginine-deprivation-therapy","display_name":"arginine deprivation therapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/malignant-pleural-mesothelioma","display_name":"malignant pleural mesothelioma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9129999876022339},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6499999761581421},{"id":"https://openalex.org/keywords/argininosuccinate","display_name":"argininosuccinate","score":0.8949999809265137},{"id":"https://openalex.org/keywords/il-1alpha","display_name":"IL-1\u03b1","score":0.8830000162124634},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cxcr2","display_name":"CXCR2","score":0.9150000214576721},{"id":"https://openalex.org/keywords/macrophage-infiltration","display_name":"macrophage infiltration","score":0.6769999861717224},{"id":"https://openalex.org/keywords/clodronate-liposomes","display_name":"clodronate liposomes","score":0.9240000247955322},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.6724392771720886},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6412593722343445},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.354605495929718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3247939944267273},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17132222652435303}],"mesh":[{"descriptor_ui":"D000086002","descriptor_name":"Mesothelioma, Malignant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001120","descriptor_name":"Arginine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001124","descriptor_name":"Argininosuccinate Synthase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001124","descriptor_name":"Argininosuccinate Synthase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006867","descriptor_name":"Hydrolases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008654","descriptor_name":"Mesothelioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008654","descriptor_name":"Mesothelioma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s43440-023-00480-6","doi":"https://doi.org/10.1007/s43440-023-00480-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s43440-023-00480-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s43440-023-00480-6.pdf","source":{"id":"https://openalex.org/S180401253","display_name":"Pharmacological Reports","issn_l":"1734-1140","issn":["1734-1140","2299-5684"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10227144","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10227144","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10227144/pdf/43440_2023_Article_480.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Rep","raw_type":"Text"},{"id":"pmid:37010783","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37010783","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/97603","doi":null,"is_oa":true,"landing_page_url":"https://qmro.qmul.ac.uk/xmlui/handle/123456789/97603","pdf_url":"https://qmro.qmul.ac.uk/xmlui/bitstream/123456789/97603/2/A%20role%20for%20macrophages%20under%20cytokine%20control%20in%20mediating%20resistance%20to%20ADI-PEG20%20%28pegargiminase%29%20in%20ASS1-deficient%20mesothe.pdf","source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1007/s43440-023-00480-6","doi":"https://doi.org/10.1007/s43440-023-00480-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s43440-023-00480-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s43440-023-00480-6.pdf","source":{"id":"https://openalex.org/S180401253","display_name":"Pharmacological Reports","issn_l":"1734-1140","issn":["1734-1140","2299-5684"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7200000286102295,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1734555535","display_name":null,"funder_award_id":"006836 QM","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"},{"id":"https://openalex.org/G4346503378","display_name":null,"funder_award_id":"MRCCRTF11-8","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G4702364530","display_name":null,"funder_award_id":"C12522/A8632","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8189177448","display_name":null,"funder_award_id":"MRD0240","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"}],"funders":[{"id":"https://openalex.org/F4320315977","display_name":"Barts Charity","ror":"https://ror.org/0513pp416"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320055","display_name":"British Lung Foundation","ror":"https://ror.org/05qnwyb92"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362506830.pdf","grobid_xml":"https://content.openalex.org/works/W4362506830.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1843927557","https://openalex.org/W1968261414","https://openalex.org/W1968486675","https://openalex.org/W1971620413","https://openalex.org/W1971750711","https://openalex.org/W1973387776","https://openalex.org/W1974380503","https://openalex.org/W1991863108","https://openalex.org/W1993677761","https://openalex.org/W1996190625","https://openalex.org/W2027449497","https://openalex.org/W2032131517","https://openalex.org/W2036607853","https://openalex.org/W2038500860","https://openalex.org/W2042750357","https://openalex.org/W2060778600","https://openalex.org/W2066538173","https://openalex.org/W2075806787","https://openalex.org/W2076743146","https://openalex.org/W2081098333","https://openalex.org/W2083183631","https://openalex.org/W2092982811","https://openalex.org/W2094957481","https://openalex.org/W2102627969","https://openalex.org/W2103456976","https://openalex.org/W2105949723","https://openalex.org/W2106712645","https://openalex.org/W2117692326","https://openalex.org/W2119785831","https://openalex.org/W2129920232","https://openalex.org/W2134730633","https://openalex.org/W2135849415","https://openalex.org/W2143172913","https://openalex.org/W2143679629","https://openalex.org/W2147998910","https://openalex.org/W2157316821","https://openalex.org/W2161286605","https://openalex.org/W2163035374","https://openalex.org/W2483486587","https://openalex.org/W2512678052","https://openalex.org/W2604413507","https://openalex.org/W2737046088","https://openalex.org/W2892293198","https://openalex.org/W2903614074","https://openalex.org/W2921622709","https://openalex.org/W3007405353","https://openalex.org/W3007538222","https://openalex.org/W3012959697","https://openalex.org/W3083661804","https://openalex.org/W3109484360","https://openalex.org/W3122627530","https://openalex.org/W3127072102","https://openalex.org/W4322503007"],"related_works":["https://openalex.org/W2245128592","https://openalex.org/W2040450347","https://openalex.org/W3133823911","https://openalex.org/W3083661804","https://openalex.org/W1973308486","https://openalex.org/W2602511395","https://openalex.org/W4362596043","https://openalex.org/W4381435871","https://openalex.org/W2025586418","https://openalex.org/W2767687478"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pegylated":[1],"arginine":[2,7,243],"deiminase":[3],"(ADI-PEG20;":[4],"pegargiminase)":[5],"depletes":[6],"and":[8,91,100,103,139,143,158,187,190,207,248],"improves":[9],"survival":[10],"outcomes":[11],"for":[12,246],"patients":[13,53,112,194],"with":[14,54,71,113,177,195],"argininosuccinate":[15,104,161,192,226],"synthetase":[16],"1":[17],"(ASS1)-deficient":[18],"malignant":[19],"pleural":[20],"mesothelioma":[21,230,247],"(MPM).":[22],"Optimisation":[23],"of":[24,32,80,123,141,228],"ADI-PEG20-based":[25],"therapy":[26,245],"will":[27],"require":[28],"a":[29,134],"deeper":[30],"understanding":[31],"resistance":[33,236],"mechanisms,":[34],"including":[35],"those":[36],"mediated":[37],"by":[38,75,97,231],"the":[39,160,165,212],"tumor":[40,63,89],"microenvironment.":[41],"Here,":[42],"we":[43,182],"sought":[44],"to":[45,169,241],"reverse":[46],"translate":[47],"increased":[48,191],"tumoral":[49],"macrophage":[50,205],"infiltration":[51,206],"in":[52,86,145,154,164,193,211],"ASS1-deficient":[55,229],"MPM":[56,88,126,147,171,196],"relapsing":[57],"on":[58,198],"pegargiminase":[59],"therapy.":[60],"METHODS:":[61],"Macrophage-MPM":[62],"cell":[64,127,148,166,172],"line":[65],"(2591,":[66],"MSTO,":[67],"JU77)":[68],"co-cultures":[69],"treated":[70],"ADI-PEG20":[72],"were":[73,84,95,106],"analyzed":[74],"flow":[76],"cytometry.":[77],"Microarray":[78,129],"experiments":[79],"gene":[81,130],"expression":[82,131],"profiling":[83],"performed":[85,107],"ADI-PEG20-treated":[87,124,146],"cells,":[90],"macrophage-relevant":[92],"genetic":[93],"\"hits\"":[94],"validated":[96],"qPCR,":[98],"ELISA,":[99],"LC/MS.":[101],"Cytokine":[102],"analyses":[105],"using":[108],"plasma":[109,185],"from":[110],"pegargiminase-treated":[111],"MPM.":[114],"RESULTS:":[115],"We":[116,150],"identified":[117],"that":[118,152,159,222],"ASS1-expressing":[119],"macrophages":[120,155],"promoted":[121],"viability":[122,173],"ASS1-negative":[125],"lines.":[128,149],"data":[132,220],"revealed":[133],"dominant":[135],"CXCR2-dependent":[136,188],"chemotactic":[137],"signature":[138],"co-expression":[140],"VEGF-A":[142,186],"IL-1\u03b1":[144],"confirmed":[151],"ASS1":[153],"was":[156],"IL-1\u03b1-inducible":[157],"concentration":[162],"doubled":[163],"supernatant":[167],"sufficient":[168],"restore":[170],"under":[174],"co-culture":[175],"conditions":[176],"ADI-PEG20.":[178,199],"For":[179],"further":[180],"validation,":[181],"detected":[183],"elevated":[184],"cytokines,":[189],"progressing":[197],"Finally,":[200],"liposomal":[201],"clodronate":[202],"depleted":[203],"ADI-PEG20-driven":[204],"suppressed":[208],"growth":[209],"significantly":[210],"MSTO":[213],"xenograft":[214],"murine":[215],"model.":[216],"CONCLUSIONS:":[217],"Collectively,":[218],"our":[219],"indicate":[221],"ADI-PEG20-inducible":[223],"cytokines":[224],"orchestrate":[225],"fuelling":[227],"macrophages.":[232],"This":[233],"novel":[234],"stromal-mediated":[235],"pathway":[237],"may":[238],"be":[239],"leveraged":[240],"optimize":[242],"deprivation":[244],"related":[249],"arginine-dependent":[250],"cancers.":[251]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-05T00:00:00"}